Invest now
Nectar Lifesciences Profit & Loss Annual
BSE: 532649 | NSE: NECLIFE | ISIN: INE023H01027 | Sector: Biotechnology & Drugs10.60 +0.21 (2.02%)Updated : 07 Aug 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Operating Expense | 61.04 | 0.81 | 1,591.73 | 1,528.87 |
| Other Net | 7.28 | 1.85 | 2.97 | 3.34 |
| Diluted Weighted Average Shares | 21.86 | 22.42 | 22.43 | 22.43 |
| Depreciation/ Amortization | 0.34 | 0.62 | 60.72 | 59.12 |
| Total Extraordinary Items | -235.54 | -114.38 | - | - |
| Operating Income | -59.03 | -0.78 | 92.36 | -5.20 |
| Net Income | -292.89 | -113.68 | 5.00 | -24.18 |
| Income Availableto Com Excl Extra Ord | -57.35 | 0.70 | 5.00 | -24.18 |
| Other Operating Expenses Total | 58.79 | 0.10 | -1.52 | -0.91 |
| Net Income Before Taxes | -87.88 | 1.07 | 18.27 | -42.42 |
| Net Income After Taxes | -57.35 | 0.70 | 5.00 | -24.18 |
| Income Availableto Com Incl Extra Ord | -292.89 | -113.68 | 5.00 | -24.18 |
| Costof Revenue Total | 0.00 | 0.00 | 1,368.16 | 1,317.40 |
| Gross Profit | 2.01 | 0.03 | 315.93 | 206.27 |
| Interest Inc( Exp) Net- Non- Op Total | -36.13 | 0.00 | -77.05 | -80.97 |
| Diluted Net Income | -292.89 | -113.68 | 5.00 | -24.18 |
| Provisionfor Income Taxes | -30.53 | 0.37 | 13.27 | -18.24 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | -57.35 | 0.70 | 5.00 | -24.18 |
| Total Revenue | 2.01 | 0.03 | 1,684.09 | 1,523.67 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 2.01 | 0.03 | 1,684.09 | 1,523.67 |
| Selling/ General/ Admin Expenses Total | 1.91 | 0.08 | 164.38 | 153.26 |
| Diluted Normalized EPS | -2.62 | 0.03 | 0.22 | -2.25 |
| Diluted EPS Excluding Extra Ord Items | -2.62 | 0.03 | 0.22 | -1.08 |
| Gain( Loss)on Saleof Assets | - | - | 0.00 | 40.41 |
| Unusual Expense( Income) | - | - | - | 0.00 |
*All figures in crores except per share values
Nectar Lifesciences Quick Links
Nectar Lifesciences Dividend Nectar Lifesciences Bonus Nectar Lifesciences News Nectar Lifesciences AGM Nectar Lifesciences Rights Nectar Lifesciences Splits Nectar Lifesciences Board Meetings Nectar Lifesciences Key Metrics Nectar Lifesciences Shareholdings Nectar Lifesciences Balance Sheet Nectar Lifesciences Cashflow Nectar Lifesciences Q1 Results Nectar Lifesciences Q2 Results Nectar Lifesciences Q3 Results Nectar Lifesciences Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
2,427.00+57.00(2.41%)
1,653.95+18.95(1.16%)
3,443.60+28.60(0.84%)
1,093.40-56.50 (-4.91%)
2,007.00-82.25 (-3.94%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.